CYTIVA virtual half-day forum

Thursday, 29 September 2022 04:22

Half-day virtual event from Cytiva: How biotech startups and translational researchers can prepare to bring innovative treatments to patients

Cytiva has invited several noteworthy colleagues from our industry to share their experience in an intimate online forum.

Join guests from THT Biomaterials (Vienna, AT), Charité (Berlin, DE), Prime Vector Technologies (Tübingen, DE), and a few Cytiva mentors who will discuss the challenges, triumphs, and key considerations for the development and delivery of novel therapies to patients.

In this virtual half-day forum, Cytiva invites industry leaders to share their experiences with overcoming obstacles and bringing novel therapies to patients. Join for guidance on what to expect on the translational journey along with how to avoid common pitfalls as you get started.
 
The program will be presented in two sessions with a 20-minute intermission. It will end with a roundtable discussion where you will have the chance to ask the experts your questions on how best to bridge basic research and clinical trials

When: Tuesday, 18 Oct, from 14:00 – 18:00 pm

More details: registration page - sign up and participate.

Even if your schedule conflicts, you are encouraged to register, as you will be sent a recording after the event.

Published in Allgemeine News